CUSIP: 761640101
What is CUSIP 761640101?
CUSIP 761640101 identifies RNN - REXAHN PHARMACEUTICALS INC - COM in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Open recent reporting periods for CUSIP 761640101:
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2018 Q4 | 0 | $0 | -$36,000 | 0 | |
| 2018 Q3 | 20,000 | $36,000 | $1.80 | 1 | |
| 2018 Q2 | 20,000 | $28,000 | $1.40 | 1 | |
| 2018 Q1 | 20,000 | $30,000 | $1.50 | 1 | |
| 2017 Q4 | 20,000 | $40,000 | $2.00 | 1 | |
| 2017 Q3 | 20,000 | $48,000 | $2.40 | 1 | |
| 2017 Q2 | 20,000 | $57,000 | -$7,699,026 | $2.85 | 1 |
| 2017 Q1 | 14,303,307 | $7,295,026 | +$761,427 | $0.51 | 29 |
| 2016 Q4 | 22,544,248 | $3,197,000 | -$1,019,680 | $0.14 | 26 |
| 2016 Q3 | 29,669,875 | $6,231,000 | +$2,157,773 | $0.21 | 26 |
| 2016 Q2 | 19,351,118 | $4,862,000 | -$810,066 | $0.25 | 27 |
| 2016 Q1 | 22,567,817 | $7,448,000 | +$4,530,689 | $0.33 | 32 |
| 2015 Q4 | 8,822,185 | $3,203,000 | -$119,708 | $0.36 | 27 |
| 2015 Q3 | 8,758,132 | $4,553,000 | -$65,109 | $0.52 | 26 |
| 2015 Q2 | 8,823,296 | $5,360,000 | +$409,934 | $0.61 | 32 |
| 2015 Q1 | 8,142,981 | $5,942,000 | +$58,482 | $0.73 | 32 |
| 2014 Q4 | 8,074,442 | $5,649,600 | +$675,094 | $0.70 | 36 |
| 2014 Q3 | 7,050,636 | $5,708,000 | -$474,171 | $0.81 | 29 |
| 2014 Q2 | 7,543,526 | $6,562,050 | -$4,889,221 | $0.87 | 33 |
| 2014 Q1 | 11,959,561 | $12,917,776 | +$7,942,595 | $1.08 | 35 |